GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | COL2A1 | multiple interactions | EXP | | 6480464 | CTD | [TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA; IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]; resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]] | PMID:26526931 | COL2A1 | increases expression | ISO | Col2a1 (Rattus norvegicus) | 6480464 | CTD | Ascorbic Acid results in increased expression of COL2A1 mRNA | PMID:15372504 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |